|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pourhoseingholi MA: Increased burden of
colorectal cancer in Asia. World J Gastrointest Oncol. 4:68–70.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Byeon JS, Yang SK, Kim TI, Kim WH, Lau JY,
Leung WK, Fujita R, Makharia GK, Abdullah M, Hilmi I, et al:
Colorectal neoplasm in asymptomatic Asians: A prospective
multinational multicenter colonoscopy survey. Gastrointest Endosc.
65:1015–1022. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Michael MZ, O'Connor SM, van Holst
Pellekaan NG, Young GP and James RJ: Reduced accumulation of
specific microRNAs in colorectal neoplasia. Mol Cancer Res.
1:882–891. 2003.PubMed/NCBI
|
|
8
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Earle JS, Luthra R, Romans A, Abraham R,
Ensor J, Yao H and Hamilton SR: Association of microRNA expression
with microsatellite instability status in colorectal
adenocarcinoma. J Mol Diagn. 12:433–440. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang J, Tian X, Han R, Zhang X, Wang X,
Shen H, Xue L, Liu Y, Yan X, Shen J, et al: Downregulation of
miR-486-5p contributes to tumor progression and metastasis
by targeting protumorigenic ARHGAP5 in lung cancer.
Oncogene. 33:1181–1189. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oh HK, Tan AL, Das K, Ooi CH, Deng NT, Tan
IB, Beillard E, Lee J, Ramnarayanan K, Rha SY, et al: Genomic loss
of miR-486 regulates tumor progression and the OLFM4
antiapoptotic factor in gastric cancer. Clin Cancer Res.
17:2657–2667. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hari DM, Leung AM, Lee JH, Sim MS, Vuong
B, Chiu CG and Bilchik AJ: AJCC Cancer Staging Manual 7th edition
criteria for colon cancer: Do the complex modifications improve
prognostic assessment? J Am Coll Surg. 217:181–90. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gedaly R, Angulo P, Hundley J, Daily MF,
Chen C, Koch A and Evers BM: PI-103 and sorafenib inhibit
hepatocellular carcinoma cell proliferation by blocking
Ras/Raf/MAPK and PI3K-AKT-mTOR pathways. Anticancer Res.
30:4951–4958. 2010.PubMed/NCBI
|
|
15
|
Chen M, Gu J, Delclos GL, Killary AM, Fan
Z, Hildebrandt MA, Chamberlain RM, Grossman HB, Dinney CP and Wu X:
Genetic variations of the PI3K-AKT-mTOR pathway and clinical
outcome in muscle invasive and metastatic bladder cancer patients.
Carcinogenesis. 31:1387–1391. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao L and Vogt PK: Class I PI3K in
oncogenic cellular transformation. Oncogene. 27:5486–5496. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Urick ME, Rudd ML, Godwin AK, Sgroi D,
Merino M and Bell DW: PIK3R1 (p85α) is somatically mutated at high
frequency in primary endometrial cancer. Cancer Res. 71:4061–4067.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang Y, Gao S, Wu S, Song P, Sun X, Hu X,
Zhang S, Yu Y, Zhu J, Li C, et al: Multilayered molecular profiling
supported themonoclonal origin of metastatic renal cell carcinoma.
Int J Cancer. 135:78–87. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Philp AJ, Campbell IG, Leet C, Vincan E,
Rockman SP, Whitehead RH, Thomas RJ and Phillips WA: The
phosphatidylinositol 3′-kinase p85alpha gene is an oncogene in
human ovarian and colon tumors. Cancer Res. 61:7426–7429.
2001.PubMed/NCBI
|
|
20
|
Vandooren J, Van den Steen PE and
Opdenakker G: Biochemistry and molecular biology of gelatinase B or
matrix metalloproteinase-9 (MMP-9): The next decade. Crit Rev
Biochem Mol Biol. 48:222–272. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mook OR, Frederiks WM and Van Noorden CJ:
The role of gelatinases in colorectal cancer progression and
metastasis. Biochim Biophys Acta. 1705:69–89. 2004.PubMed/NCBI
|
|
22
|
Groblewska M, Siewko M, Mroczko B and
Szmitkowski M: The role of matrix metalloproteinases (MMPs) and
their inhibitors (TIMPs) in the development of esophageal cancer.
Folia Histochem Cytobiol. 50:12–19. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tutar L, Tutar E and Tutar Y: MicroRNAs
and cancer; an overview. Curr Pharm Biotechnol. 15:430–437. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zheng QF, Zhang JY, Wu JS, Zhang Y, Liu M,
Bai L, Zhang JY, Zhao J, Chen Y, Duan ZP and Zheng SJ: Upregulation
of miRNA-130a represents good prognosis in patients With
HBV-related acute-on-chronic liver failure: A prospective study.
Medicine. 95:e26392016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang XP, Hou J, Shen XY, Huang CY, Zhang
XH, Xie YA and Luo XL: MicroRNA-486-5p, which is downregulated in
hepatocellular carcinoma, suppresses tumor growth by targeting
PIK3R1. FEBS J. 282:579–594. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Björklund M and Koivunen E:
Gelatinase-mediated migration and invasion of cancer cells. Biochim
Biophys Acta. 1755:37–69. 2005.PubMed/NCBI
|
|
27
|
Morini M, Mottolese M, Ferrari N, Ghiorzo
F, Buglioni S, Mortarini R, Noonan DM, Natali PG and Albini A: The
alpha 3 beta 1 integrin is associated with mammary carcinoma cell
metastasis, invasion, and gelatinase B (mmp-9) activity. Int J
Cancer. 87:336–342. 2000. View Article : Google Scholar : PubMed/NCBI
|
